#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma
Click to read this study in Clinical Cancer Research.
Tag: Erlotinib
Adjuvant erlotinib increased overall survival when compared to chemotherapy in stage IIIA EGFR-mutant non-small cell lung cancer
1. Erlotinib showed an overall survival benefit and improved 5-year survival rates when compared to chemotherapy. 2. Disease-free survival was ...
No benefit of erlotinib in combined hepatocellular carcinoma treatment
1. In a phase III trial of over 700 patients with hepatocellular carcinoma (HCC), there was no significant difference in ...
Erlotinib does not demonstrate increased survival in ovarian epithelial carcinomas
Image: PD Sisyphus 1. Patients with previously platinum-sensitive ovarian cancer showed no increase in progression-free survival or overall survival when ...